Parkinson disease: Diffusion MR imaging to detect nigrostriatal pathway loss in a marmoset model treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

Radiology

Volumn 275, Issue 2, 2015, Pages 430-437

  Hikishima, Keigo ^a,b   Ando, Kiyoshi ^b   Yano, Ryutaro ^a,b   Kawai, Kenji ^b   Komaki, Yuji ^a,b   Inoue, Takashi ^b   Itoh, Toshio ^b   Yamada, Masayuki ^c   Momoshima, Suketaka ^a   Okano, Hirotaka J ^d   Okano, Hideyuki ^a,e  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b CENTRAL INSTITUTE FOR EXPERIMENTAL ANIMALS   (Japan)

^c FUJITA HEALTH UNIVERSITY   (Japan)

^d JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALLITRICHINAE; CONTROLLED STUDY; CORPUS STRIATUM; DENERVATION; DIAGNOSTIC IMAGING; DIFFUSION TENSOR IMAGING; DOPAMINERGIC NERVE CELL; HISTOPATHOLOGY; IMAGE ANALYSIS; IMAGE DISPLAY; MALE; NERVE DEGENERATION; NEUROIMAGING; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RIGHT HEMISPHERE; SUBSTANTIA NIGRA; ANIMAL; CALLITHRIX; DIFFUSION WEIGHTED IMAGING; DISEASE MODEL; EVALUATION STUDY; NERVE TRACT; PATHOLOGY;

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; CALLITHRIX; CORPUS STRIATUM; DIFFUSION MAGNETIC RESONANCE IMAGING; DISEASE MODELS, ANIMAL; MALE; NEURAL PATHWAYS; PARKINSON DISEASE; SUBSTANTIA NIGRA;

EID: 84929017889     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.14140601     Document Type: Article

References (35)

1. Jankovic J. Parkinson's disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry 2008;79(4):368-376.
2. Le Bihan D, van Zijl P. From the diffusion coefficient to the diffusion tensor. NMR Biomed 2002;15(7-8):431-434.
3. Mori S, Zhang J. Principles of diffusion tensor imaging and its applications to basic neuroscience research. Neuron 2006;51(5):527-539.
4. Yoshikawa K, Nakata Y, Yamada K, Nakagawa M. Early pathological changes in the parkinsonian brain demonstrated by diffusion tensor MRI. J Neurol Neurosurg Psychiatry 2004;75(3):481-484.
5. Ziegler E, Rouillard M, André E, et al. Mapping track density changes in nigrostriatal and extranigral pathways in Parkinson's disease. Neuroimage 2014;99:498-508.
6. Gerlach M, Riederer P. Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man. J Neural Transm 1996;103(8-9):987-1041.
7. Ando K, Maeda J, Inaji M, et al. Neurobehavioral protection by single dose l-deprenyl against MPTP-induced parkinsonism in common marmosets. Psychopharmacology (Berl) 2008;195(4):509-516.
8. Ando K, Obayashi S, Nagai Y, et al. PET analysis of dopaminergic neurodegeneration in relation to immobility in the MPTP-treated common marmoset, a model for Parkinson's disease. PLoS ONE 2012;7(10):e46371.
9. Yamada M, Momoshima S, Masutani Y, et al. Diffusion-tensor neuronal fiber tractography and manganese-enhanced MR imaging of primate visual pathway in the common marmoset: preliminary results. Radiology 2008;249(3):855-864.
10. Basser PJ, Mattiello J, LeBihan D. MR diffusion tensor spectroscopy and imaging. Biophys J 1994;66(1):259-267.
11. Song SK, Sun SW, Ramsbottom MJ, Chang C, Russell J, Cross AH. Dysmyelination revealed through MRI as increased radial (but unchanged axial) diffusion of water. Neuroimage 2002;17(3):1429-1436.
12. Hikishima K, Sawada K, Murayama AY, et al. Atlas of the developing brain of the marmoset monkey constructed using magnetic resonance histology. Neuroscience 2013; 230:102-113.
13. Sun SW, Neil JJ, Song SK. Relative indices of water diffusion anisotropy are equivalent in live and formalin-fixed mouse brains. Magn Reson Med 2003;50(4):743-748.
14. Mori S, Barker PB. Diffusion magnetic resonance imaging: its principle and applications. Anat Rec 1999;257(3):102-109.
15. Paxinos G, Watson C, Petrides M, Rosa M, Tokuno H. The marmoset brain in stereotaxic coordinates. London, England: Academic Press, 2011.
16. Hardman CD, Ashwell KWS. Stereotaxic and chemoarchitectural atlas of the brain of the common marmoset. Boca Raton, Fla: CRC, 2012.
17. van der Jagt PK, Dik P, Froeling M, et al. Architectural configuration and microstructural properties of the sacral plexus: a diffusion tensor MRI and fiber tractography study. Neuroimage 2012;62(3):1792-1799.
18. Konomi T, Fujiyoshi K, Hikishima K, et al. Conditions for quantitative evaluation of injured spinal cord by in vivo diffusion tensor imaging and tractography: preclinical longitudinal study in common marmosets. Neuroimage 2012;63(4):1841-1853.
19. Hikishima K, Quallo MM, Komaki Y, et al. Population-averaged standard template brain atlas for the common marmoset (Callithrix jacchus). Neuroimage 2011;54(4):2741-2749.
20. Tapp PD, Head K, Head E, Milgram NW, Muggenburg BA, Su MY. Application of an automated voxel-based morphometry technique to assess regional gray and white matter brain atrophy in a canine model of aging. Neuroimage 2006;29(1):234-244.
21. Genovese CR, Lazar NA, Nichols T. Thresholding of statistical maps in functional neuroimaging using the false discovery rate. Neuroimage 2002;15(4):870-878.
22. Waters CM, Hunt SP, Jenner P, Marsden CD. An immunohistochemical study of the acute and long-term effects of 1-methyl- 4-phenyl-1,2,3,6-tetrahydropyridine in the marmoset. Neuroscience 1987;23(3):1025-1039.
23. Iravani MM, Syed E, Jackson MJ, Johnston LC, Smith LA, Jenner P. A modified MPTP treatment regime produces reproducible partial nigrostriatal lesions in common marmosets. Eur J Neurosci 2005;21(4):841-854.
24. Gulani V, Webb AG, Duncan ID, Lauterbur PC. Apparent diffusion tensor measurements in myelin-deficient rat spinal cords. Magn Reson Med 2001;45(2):191-195.
25. Parker GJ, Alexander DC. Probabilistic anatomical connectivity derived from the microscopic persistent angular structure of cerebral tissue. Philos Trans R Soc Lond B Biol Sci 2005;360(1457):893-902.
26. Douaud G, Jbabdi S, Behrens TE, et al. DTI measures in crossing-fibre areas: increased diffusion anisotropy reveals early white matter alteration in MCI and mild Alzheimer's disease. Neuroimage 2011;55(3):880-890.
27. Setsompop K, Kimmlingen R, Eberlein E, et al. Pushing the limits of in vivo diffusion MRI for the Human Connectome Project. Neuroimage 2013;80:220-233.
28. McNab JA, Edlow BL, Witzel T, et al. The Human Connectome Project and beyond: initial applications of 300 mT/m gradients. Neuroimage 2013;80:234-245.
29. Wu Y, Zhu YJ, Tang QY, et al. Accelerated MR diffusion tensor imaging using distributed compressed sensing. Magn Reson Med 2013 Mar 15. [Epub ahead of print]
30. Braak H, Del Tredici K, Rüb U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003;24(2):197-211.
31. Langston JW, Ballard PA Jr. Parkinson's disease in a chemist working with 1-methyl- 4-phenyl-1,2,5,6-tetrahydropyridine. N Engl J Med 1983;309(5):310.
32. Visanji NP, Brooks PL, Hazrati LN, Lang AE. The prion hypothesis in Parkinson's disease: Braak to the future. Acta Neuropathol Commun 2013;1(1):2.
33. Sasaki E, Suemizu H, Shimada A, et al. Generation of transgenic non-human primates with germline transmission. Nature 2009;459(7246):523-527.
34. Okano H, Hikishima K, Iriki A, Sasaki E. The common marmoset as a novel animal model system for biomedical and neuroscience research applications. Semin Fetal Neonatal Med 2012;17(6):336-340.
35. Okano H, Mitra P. Brain-mapping projects using the common marmoset. Neurosci Res 2014 Sep 27. [Epub ahead of print]